Literature DB >> 7685407

Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain.

J S Smith1, M J Roth.   

Abstract

We have expressed and purified from Escherichia coli a human immunodeficiency virus type 1 (HIV-1) RNase H domain consisting of amino acids 400 to 560 of reverse transcriptase with either an N- or C-terminal polyhistidine tag. The native protease cleavage site of HIV-1 reverse transcriptase is between amino acids 440 and 441. Purification on Ni(2+)-nitrilotriacetate agarose resulted in a highly active RNase H domain dependent on MnCl2 rather than MgCl2. Activity was unambiguously attributed to the purified proteins by an in situ RNase H gel assay. Residues 400 to 426, which include a stretch of tryptophans, did not contribute to RNase H activity, and the polyhistidine tag was essential for activity. Despite the requirement for a histidine tag, the recombinant RNase H proteins retained characteristics of the wild-type heterodimer, as determined by examining activity in the presence of several known inhibitors of HIV-1 RNase H, including ribonucleoside vanadyl complexes, dAMP, and a monoclonal antibody. Importantly, the isolated RNase H domain produced the same specific cleavage in tRNA(3Lys) removal as HIV-1 heterodimer, leaving the 3'-rA (adenosine 5' phosphate) residue of a model tRNA attached to the adjacent U5 sequence. This HIV-1 RNase H domain sedimented as a monomer in a glycerol gradient.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685407      PMCID: PMC237771     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1.

Authors:  J S Smith; S Y Kim; M J Roth
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

3.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

4.  RNase III cleavage of single-stranded RNA. Effect of ionic strength on the fideltiy of cleavage.

Authors:  J J Dunn
Journal:  J Biol Chem       Date:  1976-06-25       Impact factor: 5.157

5.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Human immunodeficiency virus reverse transcriptase-associated RNase H activity.

Authors:  M C Starnes; Y C Cheng
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

7.  Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli.

Authors:  M J Roth; N Tanese; S P Goff
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

8.  Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli.

Authors:  J Mous; E P Heimer; S F Le Grice
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.

Authors:  M M Lightfoote; J E Coligan; T M Folks; A S Fauci; M A Martin; S Venkatesan
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

10.  Identification and characterization of HIV-specific RNase H by monoclonal antibody.

Authors:  J Hansen; T Schulze; W Mellert; K Moelling
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  25 in total

1.  Expression of an Mg2+-dependent HIV-1 RNase H construct for drug screening.

Authors:  Richard V Farias; Deborah A Vargas; Andres E Castillo; Beatriz Valenzuela; Marie L Coté; Monica J Roth; Oscar Leon
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

2.  HIV-1 Reverse Transcriptase Polymerase and RNase H (Ribonuclease H) Active Sites Work Simultaneously and Independently.

Authors:  An Li; Jiawen Li; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2016-10-24       Impact factor: 5.157

3.  Crystal structure of the moloney murine leukemia virus RNase H domain.

Authors:  David Lim; G Glenn Gregorio; Craig Bingman; Erik Martinez-Hackert; Wayne A Hendrickson; Stephen P Goff
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 4.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

5.  The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H.

Authors:  I W Althaus; K M Franks; K B Langley; F J Kézdy; T Peterson; S E Buxser; D E Decker; L A Dolak; R G Ulrich; F Reusser
Journal:  Experientia       Date:  1996-04-15

6.  Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.

Authors:  S G Sarafianos; K Das; C Tantillo; A D Clark; J Ding; J M Whitcomb; P L Boyer; S H Hughes; E Arnold
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

7.  Allosteric suppression of HIV-1 reverse transcriptase structural dynamics upon inhibitor binding.

Authors:  James M Seckler; Mary D Barkley; Patrick L Wintrode
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

8.  Mutational analysis of the reverse transcriptase and ribonuclease H domains of the human foamy virus.

Authors:  D Kögel; M Aboud; R M Flügel
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

9.  Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.

Authors:  David Lim; Marianna Orlova; Stephen P Goff
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 10.  Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.

Authors:  James J Champoux; Sharon J Schultz
Journal:  FEBS J       Date:  2009-02-18       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.